India M&As Overtook PE Activity In 2022, Deal Momentum To Continue In 2023

Biocon-Viatris Deal Largest

 
• By Vibha Ravi
  
Dice with Deals images
Indian Pharma's M&A Activity Expected To Continue In 2023 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip